Navigation Links
Thoratec Reports First Quarter 2012 Results
Date:5/1/2012

a non-GAAP basis, other income totaled $0.7 million versus other expense of $0.2 million a year ago. Other income and expense on a non-GAAP basis is described later in this press release.

The company's GAAP effective tax rate in the first quarter of 2012 was 32.4 percent versus 34.1 percent a year ago. The non-GAAP tax rate, which is described later in this press release, was 33.1 percent versus 34.1 percent in the first quarter of 2011.

Cash and investments at the end of the first quarter of 2012 were $247.5 million versus $209.5 million at the end of fiscal 2011.

GUIDANCE FOR FISCAL 2012

The following statements are based on current expectations. These statements are forward-looking and actual results may differ materially. For a more detailed discussion of forward-looking statements, please see the additional information below.  The company updated guidance for the full year.

The company expects revenues will be in the range of $452 million to $467 million, reflecting the strong first quarter performance, as well as continued momentum in the Destination Therapy market, driven by the company's market development initiatives. 

Gross margins on a GAAP basis are expected to be in the range of 68.5 to 69.0 percent and 71.0 to 71.5 percent on a non-GAAP basis.

GAAP net income per diluted share is expected to be in the range of $1.24 to $1.34 and non-GAAP net income per diluted share in 2012 is expected to be in the range of $1.62 to $1.72.

CONFERENCE CALL/WEBCAST INFORMATION

Thoratec will hold a conference call to discuss its financial results and operating activities for all interested parties at 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern Daylight Time), today. The teleconference can be accessed by calling (719) 457-2620, passcode 8806446. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available via the Internet at

SOURCE Thoratec Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Thoratec Schedules First Quarter Conference Call, Webcast
2. Thoratec Comments on February 23rd Voluntary Medical Device Correction Notification
3. Thoratec Presentation at Leerink Swann Healthcare Conference to be Webcast
4. Thoratec Schedules Fourth Quarter Conference Call, Webcast
5. Thoratec Announces Appointment of William A. Hawkins to Board of Directors
6. Thoratec Presentation at Oppenheimer Conference to Be Webcast
7. Thoratec Corporation Authorizes Additional $50 Million Share Repurchase Program
8. Thoratec Reports Third Quarter Fiscal 2011 Results
9. Thoratec Schedules Third Quarter Conference Call, Webcast
10. Thoratec Presentation at Lazard Capital Markets Circulatory Assist Device Day to be Webcast
11. Thoratec Announces Presentations at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 2015 Actavis plc (NYSE: ACT ... , Chief Communications Officer, will retire from Actavis ... conjunction with Mayr,s retirement, Alex Kelly , ... Chief Communications Officer, effective immediately. Prior to joining ... President, Chief Communications Officer, Public Affairs and Investor ...
(Date:4/20/2015)... BILLERICA, Mass. , April 20, 2015 /PRNewswire/ ... tools for cell metabolism research, introduces the XFp ... a unique real-time assay on live cells that ... one-hour test measures both the mitochondrial and glycolytic ... values with metabolic activity under stressed conditions, induced ...
(Date:4/20/2015)... 2015 This report analyzes the worldwide markets for ... the following Product Segments: Sphygmomanometers (Aneroid Sphygmomanometers, & Digital Sphygmomanometers), ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... . Annual estimates and forecasts are provided for the period ...
Breaking Medicine Technology:Actavis Announces Retirement of Charles M. Mayr 2Actavis Announces Retirement of Charles M. Mayr 3New XFp Cell Energy Phenotype Test Determines Metabolic Potential 2New XFp Cell Energy Phenotype Test Determines Metabolic Potential 3World Blood Pressure Monitoring and Measurement Instruments Industry 2World Blood Pressure Monitoring and Measurement Instruments Industry 3World Blood Pressure Monitoring and Measurement Instruments Industry 4World Blood Pressure Monitoring and Measurement Instruments Industry 5World Blood Pressure Monitoring and Measurement Instruments Industry 6World Blood Pressure Monitoring and Measurement Instruments Industry 7World Blood Pressure Monitoring and Measurement Instruments Industry 8World Blood Pressure Monitoring and Measurement Instruments Industry 9World Blood Pressure Monitoring and Measurement Instruments Industry 10World Blood Pressure Monitoring and Measurement Instruments Industry 11World Blood Pressure Monitoring and Measurement Instruments Industry 12World Blood Pressure Monitoring and Measurement Instruments Industry 13World Blood Pressure Monitoring and Measurement Instruments Industry 14World Blood Pressure Monitoring and Measurement Instruments Industry 15World Blood Pressure Monitoring and Measurement Instruments Industry 16World Blood Pressure Monitoring and Measurement Instruments Industry 17World Blood Pressure Monitoring and Measurement Instruments Industry 18World Blood Pressure Monitoring and Measurement Instruments Industry 19World Blood Pressure Monitoring and Measurement Instruments Industry 20World Blood Pressure Monitoring and Measurement Instruments Industry 21World Blood Pressure Monitoring and Measurement Instruments Industry 22World Blood Pressure Monitoring and Measurement Instruments Industry 23World Blood Pressure Monitoring and Measurement Instruments Industry 24World Blood Pressure Monitoring and Measurement Instruments Industry 25World Blood Pressure Monitoring and Measurement Instruments Industry 26World Blood Pressure Monitoring and Measurement Instruments Industry 27World Blood Pressure Monitoring and Measurement Instruments Industry 28
... WIRE)--May 14, 2007 - Oculus Innovative,Sciences, Inc. ... the subject of a poster presentation at ... was held in,Glasgow, Scotland this past week., ... Antimicrobial,Solution in the Treatment of Infected Chronic ...
... Symptom Severity; New,Resources for Patients, Parents, WASHINGTON, May ... by the National Consumers League shows that American,asthma ... Four in,ten asthma sufferers understand asthma medication categories,somewhat ... the diagnosis, the less,knowledgeable adult patients tend to ...
Cached Medicine Technology:Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 2Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 3New Survey Finds Troubling Data on American Asthma Sufferers 2New Survey Finds Troubling Data on American Asthma Sufferers 3New Survey Finds Troubling Data on American Asthma Sufferers 4New Survey Finds Troubling Data on American Asthma Sufferers 5New Survey Finds Troubling Data on American Asthma Sufferers 6
(Date:4/21/2015)... Timonium, Maryland (PRWEB) April 21, 2015 eSight ... who are legally blind to see and, on Tuesday, May ... (LVS of MD & VA) will host an unveiling ... Timonium, MD office. LVS of MD & VA will be ... eyewear. A limited number of individual patient demonstrations will be ...
(Date:4/21/2015)... April 21, 2015 Bulk food-grade ... 3.8 out of 5, indicating generally favorable purchasing conditions ... low barriers to entry and the fact that most ... relatively short distances,” says IBISWorld research analyst Hayden Shipp. ... country, typically serving local and regional markets.” Suppliers include ...
(Date:4/21/2015)... San Antonio, TX (PRWEB) April 21, 2015 ... reconstruction, PRMA is actively involved in various components ... basic science fields. , "Breast reconstruction ... outcomes following mastectomy. Despite recent advances, many ... order to provide patients with optimal results," says ...
(Date:4/21/2015)... The Northeast Football Clinic (NEFC) has ... prep school in Byfield, MA. Applications are being accepted ... entering grades 6-12. , The outstanding professional, college, and ... coaching. , Offensive and defensive linemen and ... the most unsung positions on the field, the the ...
(Date:4/21/2015)... CA (PRWEB) April 21, 2015 ... solutions for biopharmaceutical development, today announced that the ... the University of Ottawa has acquired a Freeslate ... Screening Pressure Reactor (SPR) to accelerate current ... High-Throughput Experimentation Facility where they will be available to ...
Breaking Medicine News(10 mins):Health News:eSight Electronic Glasses That Enable The Legally Blind To See – First In The World – Coming To Maryland 2Health News:eSight Electronic Glasses That Enable The Legally Blind To See – First In The World – Coming To Maryland 3Health News:Bulk Food-Grade Transportation Services Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Bulk Food-Grade Transportation Services Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 2Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 4Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 5Health News:US Sports Camps and The Northeast Football Clinic Announce 2015 Lineman/Linebacker Clinic Schedule 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 3
... report in The Journal of the American Medical Association. ... levels with a diet supplement of folic acid alone ... University of California at San Francisco and colleagues used ... cost effectiveness of lowering levels of homocystine through grains ...
... segment with its "Smoquit" (buproprion 150mg tabs) recently. The ... decade as an antidepressant, albeit at a different dose. ... ever available for the treatment of smoking problem, is ... under medical supervision and guidance. // ,Smoking ...
... compare digital mammography with the standard technique to confirm ... more accuracy. Standard film mammography has been around for ... the scope and limitations of the technology.// ,Digital ... with dense breast tissue, because it offers higher contrast. ...
... who drink in moderation – between one and seven ... than either abstainers or heavier drinkers who consume more ... ,Dr Kenneth Mukamal and colleagues at Beth Israel ... consumption among elderly patients appeared to protect against age-related ...
... a cardiac arrest and are easier to use. Nearly ... year in the United States.// Many lives could be saved ... an automated electrical defibrillator (AED), a device which delivers an ... put more AED's in public places, like shopping malls, and ...
... developing cataracts, scientists have found. A cataract is a cloudy ... eye.As the opacity thickens, it prevents light rays from passing ... sensitive tissue lining the back of the eye. It is ... who were exposed to high levels of sunlight, or solar ...
Cached Medicine News:
... Already, the most advanced motor driven refractor, ... and faster to learn and operate. Specialized ... accuracy and precision. Our software makes operating ... transition from manual instruments or other automated ...
... Medmont AT20R places fast and ... your fingertips. Utilising standard computer ... PC environment with new testing ... is easily integrated into a ...
... The first Open Bore MR ,Siemens has ... 70 cm bore, a very short 125 cm ... create something very revolutionary: Open Bore MR. And ... imaging matrix). A unique Siemens technology, which means ...
... laser-cut stent, is the latest in a ... use after coronary arteries have been opened ... as percutaneous transluminal coronary angioplasty (PTCA). The ... features designed to optimize scaffolding, radiopacity and ...
Medicine Products: